Search results for: 'post thing'

Industry-wide fleet average CO2 emission targets for 2025 have been set to be 15% lower than 2020 levels, while 2030 levels will be 37.5% lower than 2020 levels. These targets are more stringent and are for cars only (separate targets are set for LCVs). Once the focus area for emission reduction, developments in IC engines no longer play an inte...

Despite a subdued economic outlook, 2023 is forecast to remain upbeat for the global healthcare industry, supported by steady emerging market growth, increased post-pandemic health-centric policies, rapidly aging populations in major developed nations, and higher R&D spending. Rapid technological advancements and digital transformation are improvin...

Geopolitical crises and high inflation prompted most central banks to raise interest rates in 2022, derailing the post-pandemic recovery. Energy costs increased manifold, impacting demand- and supply-side participants equally. Oil prices reached record highs as countries cut dependency on Russian imports, with the price of Brent crude oil reaching ...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

Frost & Sullivan defines workforce optimization (WFO) as a strategy to integrate disparate contact center workforce applications, monitor and analyze customer and agent interactions, and automate processes to optimize resources. WFO is an important segment of the contact center industry because it drives performance, agent engagement, and an improv...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring platforms by original equipment manufacturers (OEM...

5G will enable a new era of mobile Internet of Everything (IoE), with its lower latency and faster speeds. As a result, it will bring new participants from various industries, including transportation, manufacturing, healthcare, and entertainment. This will facilitate the evolution of business models and is expected to create economic value. 5G te...

The North American mobile communications market is defined by high-speed broadband services, continued penetration of advanced mobile devices that encourage developments in the cellular machine-to-machine (M2M) and Internet of Things (IoT) markets, and the resurgence of unlimited mobile plans. This tracker presents the metrics for Tier 1 mobile ope...